Individuals ( N = 308 ) co-infected with HCV genotype 1 ( treatment-naive or prior interferon relapsers ) and HIV [ 96 % on antiretroviral therapy ( ART ) ] received faldaprevir 120mg ( N = 123 ) or 240mg ( N = 185 ) and PegIFN/RBV .